Scott Madden - Corindus Vascular IR Contact Officer

Executive

Scott Madden is IR Contact Officer of Corindus Vascular Robotics since 2017.
Tenure 7 years
Phone508 653-3335
Webwww.corindus.com

Corindus Vascular Management Efficiency

The company has return on total asset (ROA) of (0.0117) % which means that it has lost $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0278) %, meaning that it created substantial loss on money invested by shareholders. Corindus Vascular's management efficiency ratios could be used to measure how well Corindus Vascular manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 15.43 M in liabilities with Debt to Equity (D/E) ratio of 86.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Corindus Vascular has a current ratio of 2.95, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Corindus Vascular until it has trouble settling it off, either with new capital or with free cash flow. So, Corindus Vascular's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Corindus Vascular sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Corindus to invest in growth at high rates of return. When we think about Corindus Vascular's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

John ReseburgElectronic Arts
N/A
Martin CarlesundEvolution Gaming Group
53
Louise WivenNilssonEvolution Gaming Group
44
Olesya IvanovaEvolution Gaming Group
34
Jesper BahrEvolution Gaming Group
47
Louise WiwenNilssonEvolution Gaming Group
45
Andrew UerkwitzElectronic Arts
N/A
David CraeliusEvolution Gaming Group
49
Christopher BruzzoElectronic Arts
54
Olesja IvanovaEvolution Gaming Group
33
Matt ThomlinsonElectronic Arts
N/A
Jacob KaplanEvolution Gaming Group
50
Marija RadulovicNasticElectronic Arts
N/A
Todd HaushalterEvolution Gaming Group
45
Mala SinghElectronic Arts
47
David TinsonElectronic Arts
N/A
Andres RengifoEvolution Gaming Group
35
Sebastian JohannissonEvolution Gaming Group
39
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts. Corindus Vascular operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 90 people. Corindus Vascular Robotics (CVRS) is traded on New York Stock Exchange in USA and employs 90 people.

Management Performance

Corindus Vascular Leadership Team

Elected by the shareholders, the Corindus Vascular's board of directors comprises two types of representatives: Corindus Vascular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Corindus. The board's role is to monitor Corindus Vascular's management team and ensure that shareholders' interests are well served. Corindus Vascular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Corindus Vascular's outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Madden, IR Contact Officer
Hillel Bachrach, Director
David White, Director
Jeffrey Gold, Director
Gerard Winkels, Director
Campbell Rogers, Director
John Bakewell, Director
David Handler, CEO and President and Director
Jeffrey Lightcap, Chairman of the Board
Douglas Teany, COO
Michael Mashaal, Director
James Tobin, Director
Louis Cannon, Director
Mark Toland, CEO, Director
David Long, CFO, Sr. VP, Treasurer and Secretary
Aquilla Turk, Chief Medical Officer

Corindus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Corindus Vascular a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Corindus Vascular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Corindus Vascular's short interest history, or implied volatility extrapolated from Corindus Vascular options trading.

Pair Trading with Corindus Vascular

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corindus Vascular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corindus Vascular will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in Corindus Stock

If you are still planning to invest in Corindus Vascular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Corindus Vascular's history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios